Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients-Reference-Cited by-同舟云学术

Sulfhydryl compound levels are associated with ATO-induced side effects in acute promyelocytic leukemia patients

Published:2023-07-07 Issue:1 Volume:28 Page:
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Sui Meijuan¹²,Wei Hong³,Shen Xiaohan³,Gao Keke³,Zhang Qian³,Zhang Zhuo¹

Affiliation:

1. Central Laboratory of The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China

2. Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China

3. Department of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China

Funder

Scientific Research and innovation fund of The First Affiliated Hospital of Harbin Medical University

Heilongjiang Postdoctoral Fund

Scientific Research Start-up Project of Southern University of Science and Technology Hospital

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2023.2231738

Reference25 articles.

1. Synergistic inhibition of leukemia WEHI-3 cell growth by arsenic trioxide and Hedyotis diffusa Willd extract in vitro and in vivo

2. Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

3. Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment

4. Arsenic methylation metabolism and liver injury of acute promyelocytic leukemia patients undergoing arsenic trioxide treatment

5. Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia